Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» February 2012
February 2012
Theratechnologies: Update on Motion for Authorization to Institute Class Action Against the Company
Theratechnologies: Update on Motion for Authorization to Institute Class Action Against the Company
Yahoo/MarketWire
Theratechnologies
Onyx Beats; Says 2012 Vital
Onyx Beats; Says 2012 Vital
Yahoo/Zacks
ONYX Pharmaceuticals
Vivus Drug Won't Solve U.S. Weight Woes, Says Author (video)
Vivus Drug Won't Solve U.S. Weight Woes, Says Author (video)
The Street
Vivus
Qnexa
Pharmacyclics: When The Power Of A Pipeline Overshadows The Market's Influence On Value
Pharmacyclics: When The Power Of A Pipeline Overshadows The Market's Influence On Value
Seeking Alpha
Pharmacyclics
PCI-32765
Warner Chilcott 4Q profit grows as charges fall
Warner Chilcott 4Q profit grows as charges fall
Yahoo/AP
earnings
Warner Chilcott
Merck KGaA to cut costs, jobs
Merck KGaA to cut costs, jobs
Reuters
layoffs
Merck KGaA
Sanofi considers expanding in Ukraine pharma market
Sanofi considers expanding in Ukraine pharma market
The Pharma Letter
Ukraine
Sanofi
KV Pharmaceutical filing: ‘Future in doubt’
KV Pharmaceutical filing: ‘Future in doubt’
Bizjournals.com
KV Pharmaceutical
Some antipsychotics raise risks of death in dementia patients - study
Some antipsychotics raise risks of death in dementia patients - study
Pharma Times, UK
dementia
antipsychotics
Otsuka
Abilify
Bristol-Myers Squibb
AstraZeneca
Seroquel
Haldol
JNJ
Eli Lilly
Zyprexa
Geodon
Pfizer
Risperdal
Glaxo Sues XenoPort Over Contract for Restless-Leg Medicine
Glaxo Sues XenoPort Over Contract for Restless-Leg Medicine
Bloomberg Businessweek
GSK
restless legs syndrome
XenoPort
Horizant
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »